Read More
Newsletter Signup | Join Community | Cancer Types
Vidaza® May Provide Alternative Treatment for Elderly Patients with AML.
Cancer Connect
Asciminib shows superior responses compared to Bosulif for treatment of chronic myeloid leukemia.
MedMaven
Connect with Others at Top Cancer Centers - Second Opinion Options...
TraceyS
Studies continue to demonstrate that incorporation of Blincyto into ALL treatment improves patient outcomes.
Venclexta® expands treatment options for AML - ASCO 2020 update in elderly AML patients confirms benefit.
FDA Approves Venclexta, Daurismo, and Xospata Precision Cancer Medicines for Treatment of Acute Myeloid Leukemia
Brukinsa is a novel BTK inhibitor with encouraging anti-cancer activity in the management of CLL/SLL.
Zanubrutinib, obinutuzumab, venetoclax (BOVen) promising new treatment for Chronic Lymphocytic Leukemia and lymphomas.
Sustained progression free and overall survival benefits with Venclexta combined with Rituxan or Imbruvica.
BruceLO
Calquence side effects
considering CAR T for ALL - anyone been through it yet?
looking for others to share their experience with stem cell transplant for leukemia.
